Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Basware Oyj Regulatory Filings 2015

Dec 22, 2015

3257_rns_2015-12-22_9240e2a2-5113-479a-9746-ac0c7944430f.html

Regulatory Filings

Open in viewer

Opens in your device viewer

Disclosure 329180

BasWare - Company Announcement

Basware signs e-invoicing agreement with global pharmaceutical corporation

Basware Corporation, stock exchange release, December 22, 2015 at 15:00 Basware signs e-invoicing agreement with global pharmaceutical corporation Basware has signed an agreement for the delivery of e-invoicing services with a global pharmaceutical corporation. The agreement includes e-invoice sending, printing, customer service management and activation services. The services will be implemented in 13 countries across Europe. The value of the agreement exceeds EUR 1.0 million over thirty months. "With Basware services, this customer can cut costs and complexity by automating the processing of the over 600,000 invoices they send to their customers annually. Where necessary, we will print the invoices for their customers who cannot yet receive e-invoices and in the process enable even more of their customers to adopt and reap the benefits of e-invoicing quickly and easily and generate more value through their participation across the Basware Commerce Network", says Esa Tihilä, CEO, Basware Corporation. For more information, please contact: Esa Tihilä, CEO, Basware Corporation Tel. +358 40 480 7098 Distribution: Nasdaq Helsinki Key media www.basware.com/investors [HUG#1975396]